Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 8Other 2Thoracic 1Sarcoma 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Xerostomia 2Squamous Cell Carcinoma of Head and Neck 2Radiation Injuries 2Mucositis 2Head and Neck Neoplasms 2Salivary Gland Neoplasms 1Deglutition Disorders 1

Interventions

Cisplatin 4Radiotherapy 3Radiation 3Amifostine 2pegfilgrastim 1Vaccinium myrtillus extract 1Tramadol 1Surgical Procedures, Operative 1Selenomethionine 1Radiotherapy, Intensity-Modulated 1Paclitaxel 1Neck Dissection 1Lysine 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Filgrastim 1Fibroblast Growth Factor 7 1Doxepin 1Docetaxel 1Carboplatin 1CBLB502 1Buprenorphine 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Amifostine × Other × Clear all
NCT00503776 2017-06-20

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Vanderbilt-Ingram Cancer Center

Phase 2 Terminated
41 enrolled 12 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Xerostomia, Mucositis

NCT00095927 2017-01-04

Randomized Amifostine For SCCHN

Dana-Farber Cancer Institute

Phase 2 Completed
58 enrolled
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Radiation Injuries, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡